TAG:
covid-19 testing
IVD Companies Launch New Assays, Analyzers, Automation
By Donna Marie Pocius | From the Volume XXX, No. 12 – August 21, 2023 Issue
Steep declines in SARS-CoV-2 test revenue were reported by the top in vitro diagnostics (IVD) companies in Q2 2023 earnings compared to a year earli…
Elizabeth Holmes Still Wants ‘To Contribute’ in Healthcare
By Scott Wallask | From the Volume XXX, No. 8 – May 30, 2023 Issue
CLINICL LABORATORY AND ANATOMIC PATHOLOGY PROFESSIONALS have another reason to shake …
Public IVD Companies Report Q4, Full-Year 2022 Earnings
By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue
YEAR-END AND Q4 EARNINGS REPORTS FROM MAJOR IN VITRO DIAGNOSTICS (IVD) COMPANIES pointed to a welcome sign of core diagnostic business rebounding. That’s the good news for IVD firms. The bad news? All of the SARS-CoV-2 testing revenue that th…
June 14, 2021 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXVIII, No. 8 – June 14, 2021 Issue
Is it possible to use a genetic test to predict an individual’s risk of severe infection requiring hospitalization or death from SARS-CoV-2? That is the claim of Australian-based molecular diagnostics company Genetic Technologies Limited. It recently announced an agreement with U.S.-based …
Goodbye Pandemic! Hello Ransomware!
By R. Lewis Dark | From the Volume XXVIII, No. 7 – May 24, 2021 Issue
Being first to predict an important trend’s arrival or departure can bring accolades for perceptive foresight or rebukes for getting it wrong. This issue of The Dark Report puts us on the record for making early predictions on two trends, each with the potential to financially make or brea…
Predicting Future Demand for COVID-19 Testing
By Robert Michel | From the Volume XXVIII, No. 7 – May 24, 2021 Issue
CEO SUMMARY: After 15 months of the pandemic, the nation’s clinical laboratories are at an interesting crossroads. Is the COVID-19 outbreak diminishing and close to disappearing? Or might it intensify again, particularly when the traditional influenza season arrives next fall? The…
Amazon Makes Big Play into Health, Diagnostics
By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue
CEO SUMMARY: Amazon is prepared to award $12 million in grants and is soliciting proposals for developing diagnostic technologies for detecting SARS-CoV-2 and other infectious diseases. This is the latest indication that the multi-billion-dollar enterprise would like to disrupt heal…
Amazon Sells COVID-19 Test Kit for At-Home Use by Consumers
By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue
QUIETLY AND WITHOUT MUCH ATTENTION, online retailing giant Amazon began to sell a COVID-19 molecular test to consumers for at-home testing. This is consistent with other actions Amazon has taken to generate revenue during the SARS-CoV-2 pandemic. …
IVD Firms Report Strong Growth Because of COVID-19 Testing
By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue
TO NO ONE’S SURPRISE, THOSE IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS that produce molecular tests, instruments, and automation used for COVID-19 testing reported strong growth in revenue and profits during 2020. In recent weeks, these companies issued t…
April 12, 2021 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue
One clinical laboratory company now says it provides COVID-19 testing services to all five of the major men’s professional sports leagues in the United States. On April 1, BioReference Laboratories, Inc. (BRLI), a division of Opko Health, announced a new agreement with Major League…
CURRENT ISSUE
Volume XXXI, No. 12 – September 3, 2024
This special intelligence briefing—presented in three parts—identifies the factors retarding a faster adoption of digital pathology. Also, how to protect your lab’s proprietary LDTs and assess the financial impact of compliance.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com
© 2024 The Dark Report. All rights reserved.